Abstracts Archive - Page 523 of 1683 - ATC Abstracts

2020 American Transplant Congress
Waitlisted Patients’ Preferences for Accepting and Consenting to Transplantation with Experimentally Manipulated Organs
E. J. Gordon¹, P. Abt², C. Phillips², F. Bermudez², B. Knopf¹, J. Lee¹, R. Veatch³, R. Knight⁴, P. T. Conway⁴, J. Goldstein⁵, S. Dunn⁶, P. Reese²
¹Northwestern University, Chicago, IL, ²University of Pennsylvania, Philadelphia, PA, ³Georgetown University, Washington, DC, ⁴American Association of Kidney Patients, Tampa, FL, ⁵Lung Transplant Foundation, Raleigh, NC, ⁶Donor Alliance, Denver, CO
*Purpose: Organ donor intervention research (“intervention research”) aims to increase organ quality and quantity for transplantation by protecting against organ injury and enhancing functionality. Given…
2020 American Transplant Congress
Epstein-Barr Virus (EBV)+ Post-Transplant Lymphoproliferative Disorder (PTLD) is Associated with Tumor CCL3/CCL4 Expression and an Increase in Tumor-Infiltrating Monocytes
J. Toh¹, F. Vallania¹, W. A. Haynes¹, G. Bhagat², F. E. Craig³, S. H. Swerdlow⁴, T. Tousseyn⁵, S. M. Krams¹, P. Khatri¹, O. M. Martinez¹
¹Stanford University School of Medicine, Stanford, CA, ²Columbia University Medical Center, New York City, NY, ³Mayo Clinic College of Medicine, Phoenix, AZ, ⁴University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁵Katholieke Universiteit Leuven, Leuven, Belgium
*Purpose: PTLD is a serious post-transplant complication that encompasses a spectrum of abnormal lymphoproliferations, including B cell lymphoma-type PTLDs. Although many are EBV-driven, a significant…
2020 American Transplant Congress
Lifetime Survival Estimates Following Solid Organ Transplantation in the United States
C. Graham¹, M. Skeans², Y. Ahn², C. Watson³, A. Barlev⁴
¹RTI Health Solutions, Research Triangle Park, NC, ²Chronic Disease Research Group, Minneapolis, MN, ³Atara Biotherapeutics, South San Francisco, CA, ⁴Atara Biotherapeutics, Thousand Oaks, CA
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) contains detailed patient and graft survival data for all solid organ transplants (SOT) in the United States…
2020 American Transplant Congress
The Importance of Annual Medicare Part D Plan Evaluation
L. Potter¹, E. Garrity²
¹Department of Pharmacy, University of Chicago Medicine, Chicago, IL, ²Transplant Institute, University of Chicago Medicine, Chicago, IL
*Purpose: The Medicare open enrollment period is from Oct 15 to Dec 7, annually. The purpose of this project was to objectively measure the benefit…
2020 American Transplant Congress
Significant Costs Associated with Poorly Controlled Post-Transplant Blood Glucose
H. Yerneni¹, K. Chavin², T. Srinivas¹, A. Padiyar¹
¹Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Dysglycemia is highly prevalent post-transplant. Poor glycemic control is associated with infectious and cardiovascular complications, as well as decreased patient and allograft survival. We…
2020 American Transplant Congress
Increased Transplant Surgery Advanced Practice Provider Involvement Associated with Decreased Hospital Length of Stay and Readmissions Following Kidney Transplantation
E. A. Herriman¹, J. R. Montgomery², K. J. Brown¹, K. J. Woodside¹
¹Surgery-Section of Transplantation, University of Michigan, Ann Arbor, MI, ²Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery Advanced Practice Providers (APPs) are utilized to provide complex care to transplant patients. Daily responsibilities of APPs are broad and variable across…
2020 American Transplant Congress
The Use of Scribes in Transplant Practice to Achieve Quality Outcomes and Foster Program Development
M. Debroy, K. Chavin
University Hospitals, Cleveland, OH
*Purpose: Transplantation is the most regulated surgical specialty in the US today. Transplant Centers (TC) are an increasingly pivotal component contributing to the fiscal viability…
2020 American Transplant Congress
The Role and Impact of Transplant Pharmacist Evaluation in a Pre-Kidney Transplant Clinic
B. Valdepenas, D. Choi, J. Benken, M. Campara
Pharmacy Practice and Transplant Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: The Centers for Medicare and Medicaid Services’ interpretative guidelines for conditions of participation for transplant centers define the transplant pharmacist’s role ambiguously. Limited evidence…
2020 American Transplant Congress
Accommodating Increasing Volumes without Knocking Down Walls: Update on an Infusion Center’s Growth
J. C. Estrada
Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: An increase in transplants performed at the medical center in comparison to the limited availability of outpatient infusion chairs and home infusion companies compelled…
2020 American Transplant Congress
Evaluation of the Economic Impact of a New IVD Immunoassay (Immunobiogram) for Immunosuppressive Treatment Adjustment in Kidney Transplant Recipients in Spain
C. Rubio¹, C. Jiménez², M. Crespo³, J. Portolés⁴, D. Rubio¹, T. Diez⁵, I. Portero⁵
¹Health Value, Madrid, Spain, ²La Paz Hospital, Madrid, Spain, ³Consorci Mar Parc de Salut, Barcelona, Spain, ⁴Puerta de Hierro Mahadahonda Hospital, Madrid, Spain, ⁵Biohope Scientific Solutions for Human Health SL, Madrid, Spain
*Purpose: Immunobiogram (IMBG) is a new IVD bioassay developed by Biohope SL with the aim to support clinicians in the personalized adjustment of immunosuppressive therapy…